Perinatal transmission of bloodborne infections: Difference between revisions

From IDWiki
m (: fixed title)
mNo edit summary
Line 1: Line 1:
* Main risk is for [[HIV]] and [[HBV]]
* Main risk is for [[HIV]] and [[HBV]]
* Also see [[HIV in pregnancy]] for management of an HIV-positive mother
** Note that integrase inhibitors are effective for achieving fast viral suppression


== Investigations ==
== Investigations ==
Line 44: Line 46:
** ZDV/NVP: [[Zidovudine#Neonatal HIV prophylaxis|zidovudine]] x6 weeks, plus [[nevirapine#Neonatal HIV prophylaxis|nevirapine]] x3 in the first week of life
** ZDV/NVP: [[Zidovudine#Neonatal HIV prophylaxis|zidovudine]] x6 weeks, plus [[nevirapine#Neonatal HIV prophylaxis|nevirapine]] x3 in the first week of life
* Empiric treatment:
* Empiric treatment:
** ZDV/3TC/NVP: [[Zidovudine#Neonatal HIV prophylaxis|zidovudine]] fir 6 weeks, plus [[lamivudine#Neonatal HIV prophylaxis|lamivudine]] and [[nevirapine#Neonatal HIV prophylaxis|nevirapine]] for 2 to 6 weeks
** ZDV/3TC/NVP: [[Zidovudine#Neonatal HIV prophylaxis|zidovudine]] for 6 weeks, plus [[lamivudine#Neonatal HIV prophylaxis|lamivudine]] and [[nevirapine#Neonatal HIV prophylaxis|nevirapine]] for 2 to 6 weeks (preferred)
** ZDV/3TC/RAL: [[Zidovudine#Neonatal HIV prophylaxis|zidovudine]] for 6 weeks, plus [[lamivudine#Neonatal HIV prophylaxis|lamivudine]] and [[raltegravir#Neonatal HIV prophylaxis|raltegravir]] for 2 to 6 weeks
** ZDV/3TC/RAL: [[Zidovudine#Neonatal HIV prophylaxis|zidovudine]] for 6 weeks, plus [[lamivudine#Neonatal HIV prophylaxis|lamivudine]] and [[raltegravir#Neonatal HIV prophylaxis|raltegravir]] for 2 to 6 weeks



Revision as of 19:38, 4 December 2019

  • Main risk is for HIV and HBV
  • Also see HIV in pregnancy for management of an HIV-positive mother
    • Note that integrase inhibitors are effective for achieving fast viral suppression

Investigations

Unknown maternal serostatus
  • If possible, send STAT maternal HIV serology, HBV, HCV, and syphilis; can consider viral load
  • For infant:
    • At birth send HIV, HBV (sAg, sAb, cAb), HCV-Ab, and syphilis serologies, as well as an HIV PCR (not viral load)
    • Repeat HIV PCR at 1, 2, and 4-6 months

HIV

Diagnosis

  • Up to 18 months of age, only use HIV PCR
    • In general, all infants with perinatal exposure should be checked at 14 to 21 days, 1 to 2 months, and 4 to 6 months
    • If high risk, can also check at birth and 2 to 4 weeks after stopping antiretrovirals
    • Confirm a positive result with repeat testing
  • Serology can be tested starting at 18 to 24 months

Management

Preventative management

  • Immediate management depends on maternal viral load and treatment status
  • In general, a mom with HIV should get IV zidovudine during labour
VL Antenatal Rx C-section Neonatal Rx
>1000 Any Yes ART
40-999 None Yes ART
40-999 ART Maybe ART
<40 None Maybe ART
<40 ART No Zidovudine x4 weeks
Unknown None Maybe ART
Unknown ART Maybe Unclear

Selection of antiretrovirals

Follow-up

Age Investigations Management
Birth CBC/diff, ALT, lactate, and HIV PCR Start ART as described below
7 days CBC/diff, nevirapine level Dose-adjust nevirapine if needed
14 days CBC/diff, nevirapine level, and HIV PCR Dose-adjust nevirapine if needed
4 weeks CBC/diff and ALT; ?HIV PCR? Stop nevirapine if prior HIV PCR is negative, and continue other ART
6 weeks ?HIV PCR? Stop zidovudine and lamivudine if HIV PCR has been negative
2 months Review as needed
6 months CBC/diff and ALT
18 months HIV serology Developmental assessment
3.5 years Developmental assessment
5.5 years Developmental assessment

Hepatitis B virus

  • If mother has hepatitis B, or her status is unknown, then consider post-exposure prophylaxis with hepatitis B immune globulin and hepatitis B vaccine given within 12 hours of life
    • Vaccine prevents about 90% of infections, with HBIG adding a bit more
    • HBIG can be given up to 7 days of life but is most effective when given earlier

Hepatitis C virus

  • Not urgent, as it is a chronic illness that may not manifest for decades
  • Serology to be done at 18 months for diagnosis
  • If significant anxiety, can send HCV-PCR

Further Reading